Financial Year |
March 31 2023 |
Monetary Funds |
2,040,673,198.82 |
Held-for-trading Financial Assets |
2,762,089,708.29 |
Notes Receivable |
-- |
Accounts Receivable |
36,303,901.08 |
Advances to Suppliers |
209,098,025.48 |
Other Receivables |
34,745,964.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
342,724,162.33 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,359,093,557.85 |
Other Current Assets |
786,065,742.71 |
Total Current Assets |
7,570,794,261.37 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
2,199,537,982.17 |
Under-construction Projects |
646,831,956.27 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
354,245,223.98 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
30,738,033.39 |
Deferred Income Tax Assets |
354,522,970.02 |
Other Non-Current Assets |
103,269,793.12 |
Sub-Total of Non-Current Assets |
5,257,145,556.18 |
Total Assets |
12,827,939,817.55 |
Short-Term Loans |
3,460,308,930.78 |
Trading Financial liabilities |
-- |
Notes Payable |
23,000,000.00 |
Accounts Payable |
618,333,084.76 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
133,391,860.63 |
Taxes Payable |
420,009,841.57 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
742,950,345.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
31,965,002.70 |
Other Current Liabilities |
62,444,581.32 |
Sub-Total of Current Liabilities |
7,178,228,078.12 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
719,720.81 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
96,383,436.41 |
Total Liabilities |
7,274,611,514.53 |
Paid-In Capital(Or Share Stock) |
400,010,000.00 |
Capital Surplus |
2,080,396,394.83 |
Surplus Reserve |
200,005,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
2,895,780,240.87 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,553,328,303.02 |
Owner's Equity(Stockholder's Equity) |
5,553,328,303.02 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,827,939,817.55 |